CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$83,342,517
-$232,574 QoQ
Shares Held
1,289,533
+3.8% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99821640857581.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0017835914241822427.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. HALO ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,342,517 | 1,289,533 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $83,575,091 | 1,241,829 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $92,509,242 | 1,261,375 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $69,854,068 | 1,342,831 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $111,594,182 | 1,748,851 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $85,253,692 | 1,783,177 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $101,509,244 | 1,773,397 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $93,596,013 | 1,787,548 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $67,833,045 | 1,667,479 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $64,167,069 | 1,736,122 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $64,877,313 | 1,698,359 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $60,686,223 | 1,682,457 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $64,387,385 | 1,685,975 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $91,780,041 | 1,613,006 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $63,682,293 | 1,610,579 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,348,348 | 1,257,917 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $52,848,856 | 1,325,197 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $52,056,469 | 1,294,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $53,472,476 | 1,314,466 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $55,819,924 | 1,229,243 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,704,574 | 1,144,269 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $40,408,486 | 946,113 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $24,869,210 | 946,317 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $23,999,266 | 895,161 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $15,266,565 | 848,614 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||